Glenmark Pharmaceuticals to launch DCGI-approved BRUKINSA in India for treatment of hematological malignancies
Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases
Health Minister Nadda delivers keynote address at FSSAI’s World Food Safety Day 2025
Roche’s Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites
Linerixibat new drug application accepted for review by the USFDA for cholestatic pruritus in patients with PBC
AstraZeneca’s fixed-duration Calquence-based regimens approved in EU for patients with chronic lymphocytic leukaemia
DuPont adds sterile packaging capacity of healthcare manufacturing site in Costa Rica
Fujifilm rebrands life sciences companies to strengthen position as strategic partners for life
Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy
Oxcarbazepine ER Tablets (RLD Oxtellar XR) had estimated annual sales of US$ 206 million in the US (IQVIA MAT April 2025)
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1749605099)
.jpg?v=1749605099)
